...Evaluation & Research (CBER), told reporters after the meeting. If approved, ATryn would compete with Thrombate III...
...The life-threatening nature of the condition ruled out a placebo-controlled study, and uncertain supplies of Thrombate III...
...approved because of supply shortages of Thrombate III. Epstein said FDA has received anecdotal reports of Thrombate III...

...AT), a naturally occurring anticoagulant protein. Under the agreement, CVDI can access Bayer's trial of Thrombate III...
...submission. Bayer has the right of first refusal to co-promote the product in conjunction with Thrombate III...